Seeking Blue Revisit

We developed an investment thesis based on the discounted cash flow valuations of some of the most credit worthy companies in the S&P 500.  All of them blue chips, trading at substantial discounts to their net worth, we called this “Seeking Blue”.  You can see our original analysis at http://workshops.saxangle.com/seeking-blue/.  We decided to revisit this valuation.  The bottom line is that many of these companies remain substantially undervalued.  And this is with our pessimistic scenario of zero growth and pressure on operating margins. The results from July 18,2012 are below:   Description Ticker Price  7/18/12 5/3/13 Change Pfizer PFE  $23.14  $28.96 … Read more

What really happened today

Once the dust settles, pundits and analysts will begin to start calculating what we’ve been telling you all along.  Many, many blue chip stocks are dirt cheap based on discounted cash flow analysis with the risk free rate of 2 %or even 3% on the 10 year treasury.  Stay away from cyclicals and invest in the highest credit quality stocks like Coke, McDonald’s, Verizon, JP Morgan, BP, Bristol Myers, Kellogg, Microsoft etc.  These stocks are all way undervalued.  The reason the Bernanke shot his bazooka today is that he doesn’t want to go down as the Fed Reserve Chairman that … Read more

Blue Chip Is The New Alpha – Seeking Alpha

We loved this provocative article from Seeking Alpha, especially the quote from Alexander Graham Bell.  We may be biased though as we are also long JPM,K,MSFT, INTC, MCD, PG and BP and the author, Stephen Perry, is interning for us this summer. Blue Chip Is The New AlphaJuly 30, 2012  | 3 comments  |  includes: AAPL, ABT, CL, CVX, DD, GE, IBM, JNJ, JPM, KO, MCD, MDT, MMM, MRK, MSFT, PEP, PFE, PG, T, TGT, VZ, WFC, WMT, XOMIts been difficult to find alpha in a market that is so volatile and dependent on global macro events, but I think Ive … Read more